GILEAD SCIENCES, INC. Cash & Short-Term Investments 2006-2026 | GILD
Beta
What is GILEAD SCIENCES, INC.'s current cash & short-term investments?
GILEAD SCIENCES, INC. (GILD) annual cash & short-term investments for 2025 was $7.63B, a 23.61% decline from 2024. GILEAD SCIENCES, INC. cash & short-term investments for the quarter ending March 31, 2026 was $7.64B.
What was GILEAD SCIENCES, INC.'s cash & short-term investments in 2024?
GILEAD SCIENCES, INC. annual cash & short-term investments for 2024 was $9.99B, a 37.54% increase from 2023.
What was GILEAD SCIENCES, INC.'s cash & short-term investments in 2023?
GILEAD SCIENCES, INC. annual cash & short-term investments for 2023 was $7.26B, a 13.77% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year cash & short-term investments CAGR?
GILEAD SCIENCES, INC. cash & short-term investments grew at a compound annual growth rate (CAGR) of 0.60% from FY2020 to FY2025, going from $7.41B to $7.63B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.6%
FY2020
$7.41B
→
FY2025
$7.63B
0607080910111213141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.63B | -23.6% | 10-K |
| FY2024 | $9.99B | +37.5% | 10-K |
| FY2023 | $7.26B | +13.8% | 10-K |
| FY2022 | $6.38B | -2.1% | 10-K |
| FY2021 | $6.52B | -12.0% | 10-K |
| FY2020 | $7.41B | -69.6% | 10-K |
| FY2019 | $24.35B | -19.1% | 10-K |
| FY2018 | $30.09B | +17.9% | 10-K |
| FY2017 | $25.51B | +114.5% | 10-K |
| FY2016 | $11.89B | -18.6% | 10-K |
| FY2015 | $14.61B | +44.2% | 10-K |
| FY2014 | $10.13B | +375.1% | 10-K |
| FY2013 | $2.13B | +14.5% | 10-K |
| FY2012 | $1.86B | -81.2% | 10-K |
| FY2011 | $9.90B | +371.8% | 10-K |
| FY2010 | $2.10B | +26.7% | 10-K |
| FY2009 | $1.66B | -7.4% | 10-K |
| FY2008 | $1.79B | +84.9% | 10-K |
| FY2007 | $968.1M | +18.6% | 10-K |
| FY2006 | $816.0M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →